• news.cision.com/
  • Orexo/
  • Report from Orexo AB’s extraordinary shareholders’ meeting, 16 February 2011
English

Report from Orexo AB’s extraordinary shareholders’ meeting, 16 February 2011

Report this content

The extraordinary general meeting resolved on February 16 to adopt a performance-based, long-term incentive program 2011/2021 for senior executives of Orexo. For more information about the incentive program, reference is made to the complete proposal which is attached to this report. 

 

For further information, contact:
Anders Lundström, President & CEO
Tel: +46 (0)706-67 22 66
Email: anders.lundstrom@orexo.com 

Robin Wright, EVP and CFO
Tel: +44 7720 300025
Email: robin.wright@orexo.com

Note:
This is information that Orexo AB (publ.) is required to disclose pursuant to the Swedish Securities Markets Act. The information was provided for public release on February 17, 2011 at 07:00 a.m. CET.

Tags:

orexo cancer Extraordinary General Meeting pharmaceutical company

Subscribe

Documents & Links